6. Common medications Flashcards
1
Q
Name cognitive enhancers (4)
A
- donepezil (Aricept)
- galantamine (Reminyl)
- rivastigmine (Exelon)
- memantine (Ebixa®/Namenda® (Can)/(U.S.))
2
Q
Describe: donepezil (Aricept)
- Dosing Schedule
- Indications
- Contraindications
- Side Effets
- Mechanism of Action
A
- Dosing Schedule: 5-10 mg PO daily
- Indications: Moderate to severe dementia of Alzheimer’s type
- Contraindications:
- Known hypersensitivity
- caution in untreated obstructive airways disease
- cardiac conduction abnormalities
- Active Peptic Ulcer Disease
- seizure disorder
- syncope not yet diagnosed (NYD)
- Side Effets: N/V, diarrhea, anorexia, falls, hip fracture, increased need for pacemaker insertion
- Mechanism of Action: Reversible inhibition of acetylcholinesterase
3
Q
Describe: galantamine (Reminyl®)
- Dosing Schedule
- Indications
- Contraindications
- Side Effets
- Mechanism of Action
A
- Dosing Schedule: 8-12 mg PO bid
- Indications: Mild to moderate dementia of Alzheimer’s type
- Contraindications:
- Known hypersensitivity
- caution in untreated obstructive airways disease, cardiac conduction
- abnormalities
- Active Peptic Ulcer Disease
- seizure disorder
- syncope not yet diagnosed
- Side Effets: N/V, diarrhea, anorexia, falls, hip fracture, increased need for pacemaker insertion
- Mechanism of Action: Reversible inhibition of acetylcholinesterase
4
Q
Describe: rivastigmine (Exelon®)
- Dosing Schedule
- Indications
- Contraindications
- Side Effets
- Mechanism of Action
A
- Dosing Schedule: 1.5 mg PO daily (starting) up to 6 mg PO bid
- Indications: Mild to moderate dementia of Alzheimer’s type
- Contraindications:
- Known hypersensitivity
- severe hepatic disease
- caution in untreated obstructive airways disease
- cardiac conduction abnormalities
- active peptic ulcer disease
- seizure disorder
- syncope not yet diagnosed
- Side Effets: N/V, diarrhea, anorexia, falls, hip fracture, increased need for pacemaker insertion
- Mechanism of Action: Acetylcholinesterase inhibition (reversible but very slow)
5
Q
Describe: memantine Ebixa®/Namenda® (Can)/(U.S.)
- Dosing Schedule
- Indications
- Contraindications
- Side Effets
- Mechanism of Action
A
- Dosing Schedule: 5 mg PO daily (starting) up to 10 mg PO bid
- Indications: Mild to moderate dementia of Alzheimer’s type
- Contraindications:
- Known hypersensitivity
- conditions that alkalinize urine
- caution in renal failure
- seizures
- Side Effets: Agitation, fatigue, dizziness, headache, hypertension, constipation
- Mechanism of Action: NMDA-receptor antagonist
6
Q
Name different laxatives (6)
A
- bran (All-Bran®)
- psyllium
- Metamucil®
- Prodiem Plain®
- lactulose
- Chronulac®
- Cephulac®
- Kristalose®(U.S.)
- Acilac
- Apo-Lactulose®
- Laxilose
- PMS-Lactulose (Can)
- senna
- Senokot®/Ex-lax®
- Glysennid®
- PEG 3350 (polyethyleneglycol)
- Lax-A-Day®,RestoraLAX®,Pegalax® (Can)
- Gavilax®,Healthylax® (U.S.)
- bisacodyl (Dulcolax®)
7
Q
A
8
Q
Describe: bran (All-Bran®)
- Dosing Schedule
- Indications
- Contraindications
- Side Effets
- Mechanism of Action
A
- Dosing Schedule: 1 cup OD
- Indications: Constipation
- Contraindications: -
- Side Effets: Bloating, flatus
- Mechanism of Action: Bulk-forming laxative
9
Q
Describe: psyllium
- Dosing Schedule
- Indications
- Contraindications
- Side Effets
- Mechanism of Action
A
- Dosing Schedule: 1 tsp PO tid
- Indications: Constipation, hypercholesterolemia
- Contraindications: N/V, abdominal pain, obstruction
- Side Effets: Bloating, flatus
- Mechanism of Action: Bulk-forming laxative
10
Q
Describe: lactulose
- Dosing Schedule
- Indications
- Contraindications
- Side Effets
- Mechanism of Action
A
- Dosing Schedule: 15-30 cc PO OD/bid
- Indications:
- Constipation
- hepatic encephalopathy
- bowel evacuation following barium exam
- Contraindications:
- Patients on low galactose diets
- Abdominal pain
- N/V
- Side Effets: Flatus, cramps, nausea, diarrhea
- Mechanism of Action: Hyperosmolar agent, lowers pH of colon to decrease blood ammonia levels
11
Q
Describe: senna
- Dosing Schedule
- Indications
- Contraindications
- Side Effets
- Mechanism of Action
A
- Dosing Schedule: 1-2 tabs PO daily or 10-15 cc syrup PO daily
- Indications: Constipation
- Contraindications: Abdominal pain, N/V
- Side Effets: Cramps, N/V , diarrhea
- Mechanism of Action: Stimulant laxative
12
Q
Describe: PEG 3350 (polyethylene glycol)
- Dosing Schedule
- Indications
- Contraindications
- Side Effets
- Mechanism of Action
A
- Dosing Schedule: 17 g (~1 heaping tablespoon) dissolved
in 120 to 240 mL (4 to 8 ounces) of beverage, OD
- Indications: Constipation, bowel prep (different dosing schedule)
- Contraindications: Known/suspected bowel
obstruction, known hypersensitivity, renal impairment
- Side Effets: Abdominal cramps, bloating of the stomach, diarrhea, flatulence, nausea
- Mechanism of Action: Osmotic laxative
13
Q
Describe: bisacodyl
- Dosing Schedule
- Indications
- Contraindications
- Side Effets
- Mechanism of Action
A
- Dosing Schedule: 5-15 mg PO (10 mg PR)
- Indications: Constipation
- Contraindications: Ileus, obstruction, abdominal pain, N/V, severe dehydration
- Side Effets: Cramps, pain, diarrhea
- Mechanism of Action: Stimulant laxative
14
Q
Describe pharmacologic tx of Parkinson’s Disease (3)
A
-
mainstay of treatment: levodopa/carbidopa (Sinemet®) or levodopa/benserazide (Prolopa®)
- Levodopa is a dopamine precursor; carbidopa and benserazide decrease peripheral metabolism of levodopa, decreasing side effects and increasing half-life of levodopa
- levodopa-related fluctuation: delayed onset of response (affected by mealtime), end-of-dose deterioration (“wearing-off ”), random oscillations of on-off symptoms
- major adverse effect of levodopa is dyskinesia
- Levodopa is a dopamine precursor; carbidopa and benserazide decrease peripheral metabolism of levodopa, decreasing side effects and increasing half-life of levodopa
- treatment of early PD: dopamine agonists, amantadine, MAOI
- adjuncts: dopamine agonists, MAOI, anticholinergics (especially if prominent tremors), catechol-O-methyltransferase inhibitors